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Thallium-201 myocardial imaging is of value in the early detection and 
evaluation of patients with suspected acute infarction. The extent of a 
thallium defect in an initial myocardial image may have important prog- 
nostic value. Tomographic imaging techniques hold promise for increased 
diagnostic sensitivity and more accurate quantitation of both infarcted 
and residual viable myocardium. Thallium imaging may have a special 
value in characterizing patients with cardiogenic shock and in detecting 
patients at risk for subsequent infarction or death or both, before hospital 
discharge. 
Approximately 95 percent of patients with transmural or nontransmural 
myocardial infarction can be detected with technetium-99m pyrophos- 
phate myocardial imaging if the imaging is performed 24 to 72 hours afler 
the onset of symptoms. Pyrophosphate imaging has been useful in lo- 
calizing the site and determining the extent of acute myocardtal infarction. 
The “doughnut” pattern is assocfated with a relatively large incidence 
of subsequent congestive heart failure and death. However, the clinical 
utility of this information is limited because it is usually not available when 
it is most needed, on admission to the coronary care unit. Pyrophosphate 
imaging may have an important role in the evaluation of patients during 
the early follow-up period after hospital discharge from an episode of acute 
jnfarction. The finding of a persistently positive pyrophosphate image 
suggests a poor prognosis and is associated with a relatively large inci- 
dence of subsequent myocardial infarction and death. 
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Both thallium-201 and technetium-99m pyrophosphate myocardial 
imaging are increasingly being used to evaluate patients with acute 
myocardial infarction. Since the introduction of these tracer techniques 
in the mid 197Os, they have excited the interest of the clinical investigator 
and have rapidly been applied in university and community hospitals 
throughout the world. In this report we review their current status in 
detecting and evaluating patients with acute myocardial infarction and 
to place these methods in perspective as we enter the 1980s. 
Thallium-201 Myocardial Imaging 
Physiologic and anatomic principles: Thallium-201 is taken up by 
normal myocardial cells in proportion to blood fl0w.l Within the phys- 
iologic range of blood flow the extraction of thallium by the myocardium 
is approximately 88 percent.2 Only at the extremes of the physiologic 
range of myocardial flow does the relation of thallium uptake by the 
myocardial cell and blood flow deviate. At low flows relatively more and 
at high flows relatively less thallium is extracted from the blood. 
In normal persons, thallium-201 is relatively uniformly distributed 
throughout the myocardium. The normal myocardial thallium image 
may show an area of relatively diminished uptake at the apex, because 
the apex is normally thinner than the left ventricular free wall and 
septum.3 The right ventricle is usually not well defined in a left anterior 
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oblique thallium myocardial image obtained at rest 
because the mass and blood flow per gram of the right 
ventricle are less than those of the left ventricle. How- 
ever, during exercise, tachycardia and acute pulmonary 
hypertension (conditions that result in an increase in 
right ventricular blood flow and mass), the right ven- 
tricle can be detected easily.* 
Areas of myocardial ischemia or infarction, or both, 
can be detected on thallium-201 myocardial imaging by 
the relative absence of tracer uptake in a region of the 
myocardium. Ischemia or infarction, or both, can be 
detected immediately after experimental coronary ar- 
terial ligation because blood flow, and hence thallium 
uptake, will be diminished. Ischemia can be differen- 
tiated from infarction by serial myocardial imaging and 
quantification of the redistribution of thallium-201.5 
If myocardial imaging is repeated 1 to 6 hours after the 
injection of tracer, normal areas of myocardium will lose 
thallium activity. In contrast, areas of myocardial 
ischemia will have a relative increase in activity as 
thallium distributes in time according to myocardial 
mass. Areas of permanent myocardial damage after 
myocardial infarction will show diminished thallium- 
201 activity in both initial and delayed serial images. 
The location of the defect in a thallium-201 image 
is also of interest because it can be used to predict the 
underlying anatomic disease.6 For example, defects in 
thallium uptake in the anterior apical region in an an- 
terior view or defects in the area of the interventricular 
septum in the left anterior oblique image indicate sig- 
nificant disease of the left anterior descending coronary 
artery. Lesions of this artery above the first septal 
perforator can be distinguished from those below this 
branch. Lesions above this branch can be detected by 
the finding of a defect in thallium-201 uptake involving 
the septum in a left anterior oblique view; lesions below 
this branch involve the anterior apical region in an an- 
terior view, but not the septum in the left anterior 
oblique view. This differentiation may be of clinical 
importance because it has recently been pointed out 
that lesions of the left anterior descending coronary 
artery above the first septal perforator are associated 
with a large incidence of ventricular fibrillation or 
sudden cardiac death, or both.7 Lesions in the right 
coronary artery may be detected by finding a defect on 
the diaphragmatic surface or apex in the right anterior 
oblique view; however, ‘occasionally, because of ana- 
tomic variation, lesions of the left circumflex coronary 
artery may also project there. Lesions of the latter artery 
can be detected by the finding of a tracer defect on the 
high lateral wall in a left anterior oblique or left lateral 
image. These physiologic and anatomic principles 
provide the basis for the use of thallium-201 myocardial 
imaging in the detection and evaluation of patients with 
acute myocardial infarction. 
Patients with suspected myocardial infarction 
or ischemia: Thallium-201 myocardial imaging has 
been shown to be of value in the early detection and 
evaluation of patients with suspected acute myocardial 
infarction. Patients with a diagnosis of “rule out myo- 
cardial infarction” remain a major problem in most 
medical centers. Approximately half of the patients 
admitted to the coronary care unit for suspected in- 
farction are shown not to have infarction. These pa- 
tients include those with unstable angina pectoris or 
coronary insufficiency, patients with previously known 
ischemic heart disease and acute chest pain of noncar- 
disc origin, and those with chest pain of noncardiac 
origin without underlying ischemic heart disease. If 
techniques could be developed to triage accurately pa- 
tients with suspected acute myocardial infarction, great 
savings in cost and increased effectiveness of diagnosis 
and therapeutic interventions could be realized. Al- 
though thallium-201 myocardial imaging cannot be 
expected to solve this problem entirely, there is accu- 
mulating information to suggest that it may be of value 
under special circumstances. 
During the early hours of myocardial infarction, the 
electrocardiogram may not be diagnostic of acute 
myocardial infarction. Similarly, serum creatine kinase 
may not be elevated for the first few hours after myo- 
cardial damage. In these early hours serial thallium-201 
myocardial imaging may be of value.8 If a defect in 
thallium uptake is seen in an initial myocardial image, 
myocardial infarction should be suspected and the pa- 
tient admitted to the coronary care unit for routine 
monitoring and therapy of acute myocardial infarction. 
If the defect in thallium uptake can no longer be de- 
tected on reimaging 2 to 3 hours later, acute myocardial 
ischemia without infarction or only minor infarction 
should be suspected. Patients with these findings should 
also be admitted to the coronary care unit, but mobili- 
zation and the application of diagnostic and therapeutic 
interventions for myocardial ischemia can be acceler- 
ated. In patients who have normal thallium myocardial 
uptake on both initial and serial imaging, myocardial 
ischemia or infarction is less likely, and chest pain of 
noncardiac origin should be considered. One limitation 
of this approach is that patients with prior myocardial 
infarction and scarring may have residual defects in 
thallium uptake indistinguishable from defects secon- 
dary to acute infarction even with serial imaging. A 
documented history of prior myocardial infarction 
should alert the clinician to this possibility. 
Patients with right ventricular infarction: An- 
other limitation of this approach is that right ventricular 
infarction may not be detected and a misdiagnosis of 
chest pain of noncardiac origin may be made because 
the right ventricle is often not seen in a thallium-201 
image obtained at rest. To eliminate the possibility of 
right ventricular infarction as a cause of the patient’s 
symptoms, a gated blood pool image can be obtained. 
If right ventricular infarction is present, it will be 
manifested by a poorly contracting large ventricle with 
or without concomitant left ventricular dysfunction.9 
In our experience, right ventricular infarction can often 
be diagnosed with blood pool imaging before the de- 
velopment of characteristic hemodynamic findings. 
Early in the course of right ventricular infarction, right 
ventricular filling pressure may be only slightly elevated 
although the right ventricle is markedly dilated because 
this chamber is more compliant than the left ventricle. 
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Only after volume challenge or loading will the right 
ventricular filling pressure increase in disproportion to 
left ventricular filling pressure. If both right and left 
ventricular infarction can be excluded within the first 
few hours of onset of symptoms, patients could undergo 
appropriate diagnostic fstudies more quickly to deter- 
mine the cause of the chest pain without the expense 
and stigma often associated with admission to the cor- 
onary care unit. 
Early diagnosis of acute myocardial infarction: 
Once a patient is in the coronary care unit, thallium-201 
myocardial imaging has proved a highly sensitive 
technique to detect the presence of infarction. Wackers 
et al.l”J1 in an early studly in Amsterdam found that 100 
percent of patients with either transmural or non- 
transmural infarction could be detected by the finding 
of a defect in thallium uptake in the initial image made 
within 6 hours of onset of symptoms. With increasing 
time from the onset of symptoms, the sensitivity for 
detecting infarction, especially nontransmural infarc- 
tion is diminished. In the series of Wackers et al. the 
sensitivity for detecting infarction was 58 percent after 
24 hours. 
Because sensitivity decreases with time, prompt ap- 
plication of thallium-201 is important for this approach 
to be effective. The 74 hour physical half-life of thal- 
lium-201 is long enough to permit storage of the tracer 
in the hospital nuclear pharmacy for emergency use. In 
large metropolitan areas the tracer is increasingly ac- 
cessible from centralized pharmacies. 
Diagnosis of remote infarction: Although the 
sensitivity for detection of infarction by thallium-201 
myocardial imaging diminishes with time, the detection 
of remote infarction remains greater than that for the 
electrocardiogram. In an early study of 101 patients with 
a documented old myocardial infarction (from 3 months 
to 10 years), a definite diagnosis could be made in 61 
patients using electrocardiographic criteria and in 76 
by the finding of a defect in a thallium image obtained 
at rest (p <0.01).12 
Predicting prognosis: Thallium-201 myocardial 
imaging may also be of value in predicting prognosis. 
The extent of the thallium defect has been shown to 
correlate with pathologically determined infarct size 
and with the contrast angiographic extent of asyner- 
gy.13J4 Thallium defects have been found in more than 
90 percent of patients with asynergic segments greater 
than 60 percent of the left ventricular circumference.15 
The extent of the thallium defect in an initial myocar- 
dial image in the coronary care unit has also been shown 
to have important prognostic value and to be a better 
prognostic indicator a’f subsequent survival than the 
extent of left ventricular dysfunction in a blood pool 
image.13 The extent of a thallium defect may be defined 
by relatively simple calmputer programs. The myocar- 
dial image can be circumscribed by a light pen or edge 
detection routine and radi drawn from the center of 
activity to the perimeter of the image. In a normal per- 
son there is relatively uniform activity along each radius. 
This information can be displayed graphically from 0 
to 360°. In patients with myocardial ischemia or in- 
farction, or both, the extent of the defect in thallium 
uptake can be quantitated by determining the number 
of degrees around the perimeter with decreased thal- 
lium-201 activity. With this technique it is possible to 
define a group with a relatively high mortality rate after 
myocardial infarction and one with a low risk of subse- 
quent mortality.13 
Assessing extent of myocardial damage: The ex- 
tent of myocardial damage can also be assessed with 
tomographic imaging techniques.16J7 New collimators 
have been developed that can be applied to standard 
scintillation cameras to obtain tomographic images by 
computer reconstruction techniques. Tomographic 
imaging techniques have been used to estimate the ex- 
tent of experimental myocardial infarction and when 
they are used an excellent correlation has been found 
between pathologically determined infarct size and 
estimated infarct sizer8 despite the inherent “pin- 
cushion” distortion with these collimators. Although 
experience with tomographic imaging in patients with 
acute myocardial infarction is limited, this technique 
should allow increased diagnostic sensitivity for the 
detection of infarction as well as the capacity for more 
accurate quantitation both of the infarcted and residual 
viable myocardium. (Fig. 1 and 2). 
Patients with cardiogenic shock: Thallium-201 
myocardial imaging may also be of value in assessing 
patients with cardiogenic shock. For example, patients 
with cardiogenic shock due to massive left ventricular 
damage will have an extensive defect in left ventricular 
thallium-261 uptake, often involving greater than 40 
percent of the left ventricular circumference. In those 
with persistence of a defect of this magnitude on serial 
imaging several hours later, the prognosis is poor re- 
gardless of therapy because the amount of residual 
viable myocardium is often insufficient to maintain 
adequate pump function over time. Redistribution of 
thallium into the area of the initial defect in tracer up- 
take suggests reversible myocardial ischemia and the 
possibility of improvement by intraaortic balloon 
pumping and possibly by coronary bypass graft surgery. 
Patients with cardiogenic shock and an electrocardio- 
graphic pattern of an inferior myocardial infarction may 
have massive left ventricular damage demonstrated by 
thallium imaging. Normal or almost normal left ven- 
tricular uptake of thallium suggests massive right ven- 
tricular damage. The prognosis in patients with these 
findings is good if the damage is limited to the right 
ventricle and appropriate therapy, such as plasma vol- 
ume expansion, is instituted. 
Evaluation of patients for coronary bypass sur- 
gery: Thallium-201 myocardial imaging is also of value 
in detecting areas of myocardium at risk during exercise 
for subsequent myocardial infarction and therefore for 
possible coronary arterial bypass graft surgery.r2 Ex- 
ercise electrocardiographic testing before hospital dis- 
charge after myocardial infarction has been shown to 
be useful in detecting patients at high risk for subse- 
quent infarction or death, or both.lg The appearance on 
exercise of a new tracer defect outside the area of in- 
farction detected in a thallium-201 myocardial image 
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FIG iURE 1. Tomographic thallium-201 myocardial images (t to 4) in a patient with normal coronary arteries. Note the relatively uniform thallium- 
upt ake in both the exercise (Ex) and delayed images (3 hours later). 
FIG iURE 2. Tomographic thallium-201 images in a patient with a history of myocardial infarction. Left, the images after submaximal stress; ri 
the delayed images (3 hours later). Note that the area of decreased tracer uptake is similar in both the stress and delayed images, confirming 
the area of decreased tracer uptake is due to infarction rather than ischemia. 
obtained at rest indicates a “risk” segment (that is, an 
area of viable myocardium served by a significantly 
narrowed coronary artery). In a recent study more than 
80 percent of “risk” segments confirmed on coronary 
angiography could be detected with exercise thallium- 
201 myocardial imaging.20 Although experience is still 
limited, our current procedure is to perform rate-limited 
exercise electrocardiography and thallium-201 myo- 
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cardial imaging before hospital discharge after an epi- 
sode of myocardial infarction. Patients who do not ex- 
hibit evidence of myocardial ischemia on electrocardi- 
ography and do not exhibit a new defect in thallium 
uptake on exercise are assumed to be at low risk for 
subsequent infarction or cardiac death, or both, and are 
discharged to normal activity after convalescence. Pa- 
tients who exhibit evidence of myocardial ischemia on 
electrocardiography or show evidence of a new defect 
on thallium myocardial imaging are considered for early 
coronary arteriography in order to detect candidates for 
early bypass graft surgery. To determine whether this 
approach is correct will require further experience and 
carefully controlled trials. 
Technetium-99m Pyrophosphate Imaging 
Physiologic and an.atomic principles: Myocardial 
infarction can also be detected with the uptake of 
technetium-99m pyrophosphate within an area of acute 
infarction.21 This is in contrast to thallium-201 myo- 
cardial imaging in whic:h infarction is recognized by an 
absence of tracer uptake. Since its introduction in 1974 
by Bonte et a1.21 technetium-99m pyrophosphate 
myocardial imaging has found wide clinical application. 
Although the exact mechanism of technetium-99m 
pyrophosphate uptake by infarcted myocardium is still 
being investigated, the weight of evidence suggests that 
the major mechanism is the formation of complexes 
with tissue calcium stores within the injured ce11.22 
Technetium-99m pyro’phosphate may also form com- 
plexes with damaged myocardial proteins and other 
macromolecules, but this may not be as important as the 
binding to tissue calcium. Residual myocardial blood 
flow is also of direct importance because, if there is no 
residual flow, tracer ca.nnot be delivered to the area of 
infarction. This is evident from the pattern of pyro- 
phosphate uptake in p,atients with massive myocardial 
damage in which the central necrotic area with low re- 
sidual flow fails to take up tracer, whereas the surviving 
border zone with residual collateral flow avidly takes up 
tracer resulting in a “doughnut” pattern. 
Areas of myocardial infarction can be detected ap- 
proximately 12 hours after the onset of symptoms. 
However, imaging at this time will result in a relatively 
low sensitivity for detection of infarction. Maximal 
sensitivity for detection of infarction is achieved 24 to 
72 hours after the onset of symptoms.23 After 1 to 2 
weeks, pyrophosphate uptake by the myocardium is 
usually not detected ‘but in some patients a positive 
image may persist for several weeks or months. It is 
important to wait at least 90 minutes and preferably 3 
hours after injection of pyrophosphate before imaging. 
Imaging performed earlier than 90 minutes after in- 
jection may result in a low specificity due to persistence 
of blood pool activity and the appearance of diffuse 
uptake, which may be mistaken for a positive image. 
Wherever there is a question that apparent uptake is 
due to blood pool activity, further delayed views should 
be obtained for comp,arison. Several approaches have 
been used to grade pyrophosphate images. The most 
commonly used is that recommended by Willerson et 
a1.23 Scintigrams are graded from 0 to 4+: 0 = no ac- 
tivity; l+ = minimal a.ctivity; 2+ = definite myocardial 
activity; 3+ = activity equal to bone activity; and 4+ = 
activity greater than bone activity. In this system scans 
with 2+ or greater activity are thought to suggest acute 
myocardial infarction. 
Sensitivity of test for acute infarction: If imaging 
is performed during the optimal time, 24 to 72 hours 
after onset of symptoms of acute infarction, approxi- 
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mately 95 percent of patients with transmural or non- 
transmural infarction will be detected.24 To obtain such 
a high sensitivity with a high specificity requires careful 
attention to imaging technique and the use of serial 
imaging. However, such high sensitivity for detecting 
infarction has not been a universal finding. For example, 
Lyons et a1.25 recently reported that 96 percent of pa- 
tients with transmural infarction had pyrophosphate 
uptake, but in only 82 percent was the uptake localized. 
Similarly, 88 percent of patients with nontransmural 
infarction had pyrophosphate uptake but the uptake 
was localized in only 44 percent. A relatively large pro- 
portion of patients with chest pain, unstable angina 
pectoris, congestive heart failure or pericarditis, as well 
as patients studied after resuscitation, also had pyro- 
phosphate uptake, but not a localized pattern. There- 
fore, if one requires a localized or focal pattern of uptake 
as the criterion for diagnosis of myocardial infarction, 
the sensitivity for detecting nontransmural infarction 
is relatively low, approximately 44 percent. 
Several conditions are known to cause false positive 
pyrophosphate images. They include calcific valvular 
heart disease, left ventricular aneurysm with dystrophic 
calcification, inflammation or tumors of the breast, and 
disease of the chest wall or ribs. Cardioversion with 
skeletal muscle damage may also cause pyrophosphate 
uptake.26 
Limitations of method: The major limitation of 
pyrophosphate imaging for detection of acute myocar- 
dial infarction is that in most instances the diagnosis has 
been established with serial electrocardiography and 
serum enzyme determination in 24 to 72 hours, the time 
of optimal pyrophosphate imaging. In the approximate 
one fourth to one third of patients with infarction in 
whom the diagnosis is still in doubt at 48 hours, pyro- 
phosphate imaging is of limited value in view of the 
relatively low sensitivity for detecting nontransmural 
infarction if a localized pattern is required and the fre- 
quent occurrence of the conditions known to cause false 
positive images. Although only a relatively small pro- 
portion of patients with infarction will be detected 
during the early hours of infarction with pyrophosphate 
imaging, imaging 5 hours after infarction may have some 
value. Recent experimental studies27 suggest that the 
early appearance of pyrophosphate uptake indicates 
reperfusion injury due to reversible coronary arterial 
occlusion with more rapid delivery of flow to the in- 
farcted region than would occur by collateral channels 
over 48 to 72 hours in animals with a completely oc- 
cluded vessel This approach may therefore be of value 
in detecting patients with infarction due to coronary 
arterial spasm. 
Localizing the site and extent of infarction: Py- 
rophosphate imaging has also been useful in localizing 
the site and determining the extent of acute myocardial 
infarction. For example, right ventricular infarction has 
been diagnosed by the finding of a characteristic pattern 
of pyrophosphate uptake in the left anterior oblique 
image.2s As previously pointed out, patients with the 
electrocardiographic pattern of an inferior myocardial 
infarction may have a spectrum of anatomic damage 
involving the left or the right ventricle, or both. Al- 
December 18, 1980 The American Journal of CARDIOLOGY Volume 46 1219 
IMAGING IN MYOCARDIAL INFARCTION-PITT AND THRALL 
FIGURE 3. Technetium-99m pyrophosphate tomographic myocardial imaging. A standard planar image using a high resolution (l-l RES) collimator 
is shown in the upper left panel and tomographic cuts in the same patient at 10, 7, 6, 5 and 4 centimeters (CM). The tomographic images provide 
a better estimate of the extent of infarction than does the standard planar image. 
though this differentiation has important therapeutic 
and prognostic implications, the information provided 
by pyrophosphate imaging is often too late to be of 
therapeutic importance. 
The extent of pyrophosphate uptake has also been 
correlated with the extent of myocardial infarction using 
standard imaging techniques. Good correlations be- 
tween the extent of infarct-avid agents and the extent 
of acute anterior transmural myocardial infarction have 
been found.my30 Less satisfactory correlations have been 
found in patients with inferior or posterior myocardial 
infarction because of inadequate projection of the area 
of damage when standard imaging techniques are used. 
Recently, this limitation has been overcome using to- 
mographic imaging techniques31 (Fig. 3). Excellent 
correlations between the extent of infarction deter- 
mined pathologically and the extent of pyrophosphate 
uptake have been found for transmural infarction in all 
locations using tomographic techniques. Precise cor- 
relation between the extent of pyrophosphate uptake 
and infarction in patients with nontransmural infarc- 
tion is less satisfactory because of the presence of the 
pattern of diffuse uptake in some patients. Neverthe- 
less, some correlation with the extent of damage can be 
found even in patients with nontransmural infarc- 
tion. 
The prognosis in patients with myocardial infarction 
depends on the extent of myocardial damage, both new 
and old. Patients with an old anterior transmural 
myocardial infarction may present with an acute infe- 
rior infarction or nontransmural infarction. The extent 
of pyrophosphate uptake and, similarly, creatine kinase 
release will reflect only the acute damage in these sit- 
uations. Implications as to prognosis based on infarct 
size determined from techniques that reflect only acute 
damage must of necessity be misleading. Under these 
circumstances techniques that reflect total myocardial 
damage will be of greater value. Total myocardial 
damage can be assessed from the extent of a defect in 
thallium-201 uptake or from the extent of ventricular 
dysfunction on gated blood pool imaging. For example, 
in one early study32 no significant difference could be 
found in creatine kinase release between survivors of 
infarction and those subsequently dying, whereas there 
was a significant difference in an index that reflected 
total myocardial damage, such as left ventricular ejec- 
tion fraction and percent of the left ventricular wall that 
was akinetic on blood pool imaging. 
Significance of “doughnut” imaging pattern: 
Despite these limitations pyrophosphate imaging may 
provide important prognostic information. The 
“doughnut” pattern has been found in patients with 
massive anterior transmural infarction. The essentially 
clear area without pyrophosphate uptake indicates se- 
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dial blood flow for delivery of tracer. In one study33 of 
71 patients with acute anterior myocardial infarction, 
45 were shown to have a doughnut pattern and 26 a 
“focal” pattern of uptake. Peak creatine kinase release 
in those with a doughnut pattern was 660 units com- 
pared with 344 units in those with a focal pattern (p 
CO.05). Of the patients with a doughnut pattern, 67 
percent had congestive heart failure and 9 percent died, 
whereas among those with a focal pattern, only 35 per- 
cent had congestive heart failure and none died. Simi- 
larly, Ahmad et a1.34 found late complications in all 
patients with a doughnut pattern of pyrophosphate 
imaging compared with only 43 percent of patients with 
a focal pattern of uptake and 12 percent of those with 
a diffuse pattern. The post-hospital mortality rate was 
83 percent in those with a doughnut pattern, 6 percent 
among those with a focal pattern and 0 percent among 
those with a diffuse pattern. Although these early data 
are encouraging and identification of high risk subsets 
after myocardial infarction is clearly of great impor- 
tance, a larger experience will be required to determine 
if the doughnut pattern provides prognostic information 
over and above that o.btainable by more routine clinical 
techniques, including creatine kinase release. 
Persistently positive image after infarction: One 
circumstance in which pyrophosphate imaging appears 
to provide independent prognostic information not 
readily obtainable by other techniques is the occurrence 
of persistently positive image after infarction. Olsson 
et a1.35 recently reported on 109 patients in whom py- 
rophosphate imaging was performed a mean of 31 weeks 
after infarction; 61 patients (56 percent) had a positive 
pyrophosphate image and 48 (44 percent) a negative 
image. These patients were followed up for a mean of 
50 weeks. In those with a positive pyrophosphate image 
10 percent had recurrent myocardial infarction and 16 
percent died compared with a 2 percent incidence rate 
for both myocardial infarction and for death in those 
with a negative image. They also noted an increased 
incidence of congestive heart failure and severe angina 
pectoris in those with a positive image. 
The finding of a persistently positive pyrophosphate 
image after an episo’de of acute myocardial infarction 
may be due to unresolved calcium complexes within 
the infarcted region, dystrophic myocardial calcifi- 
cation or ongoing myocardial necrosis. In the past we 
tended to think of myocardial infarction as a sudden 
event healing in 6 to 8 weeks. More likely, many patients 
with infarction have islands of viable myocardium 
within the distribution of the “infarct.” These islands 
of viable myocardium are supplied by collateral flow 
that, although adequate to preserve myocardium ini- 
tially, may be inadequate over time and during periods 
of increased oxygen demands required during stress. 
Identification of this high risk subset with a persistently 
positive pyrophosphate image suggests the need for new 
therapeutic strategies. 
Patients with unstable angina: A similar situation 
has been encountered in patients presenting with un- 
stable angina pectoris. 36 Several groups have noted that 
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approximately one fourth of patients with unstable 
angina pectoris but without serial electrocardiographic 
or serum enzyme evidence of acute myocardial infarc- 
tion have a positive pyrophosphate image. Initially it 
was thought that a positive pyrophosphate image under 
these circumstances was a false positive image. How- 
ever, recent studies suggested that a positive pyro- 
phosphate image under these circumstances may rep- 
resent subclinical myocardial necrosis. Small areas of 
myocardial necrosis are frequently seen at postmortem 
examination in patients with unstable angina pectoris 
dying of other causes and have been correlated with a 
positive pyrophosphate image. Olson et a1.36 reported 
on 199 patients with unstable angina pectoris without 
electrocardiographic or serum evidence of myocardial 
infarction; 67 (34 percent) had a positive and 132 (66 
percent) a negative pyrophosphate image. Of those with 
a positive pyrophosphate image 21 percent had subse- 
quent nonfatal myocardial infarction and 22 percent 
had’cardiac death during a mean follow-up period of 35 
weeks compared with a 3 percent incidence rate of 
nonfatal infarction and a 6 percent incidence rate of 
cardiac death in those with a negative image. It is pos- 
sible that those with a positive pyrophosphate image 
had ongoing or sporadic episodes of myocardial necrosis 
similar to those of patients with cerebrovascular disease 
and ischemic attacks. 
Identification of a high risk subset of patients with 
unstable angina has important therapeutic implica- 
tions. For example, in those with a negative image with 
a low risk of subsequent infarction and death, conser- 
vative medical therapy appears justified, whereas in 
those with a positive image more aggressive therapy, 
possibly medical or surgical, seems indicated. Failure 
to separate high and low risk subsets in any trial of 
therapy in unstable angina may lead to an inability to 
show efficacy of a therapeutic intervention and may in 
part account for the failure of the multicenter trial of 
coronary arterial bypass graft surgery to show a signif- 
icant effect of surgery on survival.37 
Clinical Applications 
Diagnostic protocol in thallium-201 imaging: We 
suggest that if, after routine clinical examination, 
electrocardiography and initial serum enzyme deter- 
mination, there is a question as to the diagnosis of acute 
myocardial infarction in a patient without a previous 
history of infarction, serial thallium-201 imaging should 
be considered. This technique will be of special value 
when applied to patients without known previous 
ischemic he& disease who present to the emergency 
room with chest pain or symptoms suspicious of acute 
myocardial infarction within the first few hours of onset 
of symptoms. The finding of a defect in thallium-201 
uptake suggests the presence of ischemic heart disease. 
If serial imaging 2 to 3 hours later demonstrates that the 
defect persists or enlarges, acute myocardial infarction 
should be suspected and the patient admitted for fur- 
ther observation. In patients with negative serial thal- 
lium-201 myocardial images but a high suspicion of 
infarction by clinical history, a blood pool image may 
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be obtained in both the right and left anterior oblique 
projections. The finding of a normal left ventricular 
ejection fraction and normal wall motion of both the 
right and left ventricles makes the presence of an acute 
infarction unlikely. 
Protocol in high risk patients to evaluate thera- 
py: In patients admitted to the coronary care unit with 
the diagnosis of acute myocardial infarction an initial 
thallium-201 myocardial image and quantification of 
the extent of thallium defect provide important prog- 
nostic information sufficient to assign patients to high 
or low risk subsets.13 To evaluate the effectiveness of 
therapeutic interventions blood pool imaging should be 
considered.3s-40 Although not reviewed in this study, 
left ventricular ejection fraction determined with blood 
pool imaging is highly reproducible and correlates well 
with values obtained with standard contrast angiogra- 
phy. In patients with complicated myocardial infarction 
and cardiogenic shock a combination of thallium-201 
myocardial imaging and blood pool imaging should be 
considered to identify those with massive irreversible 
left ventricular damage, whose prognosis is poor even 
with aggressive therapy, those with residual left ven- 
tricular ischemia or right ventricular damage and those 
whose cardiogenic shock is the result of a small strate- 
gically placed infarction (such as with rupture of a pa- 
pillary muscle or of the interventricular septum). 
Role of pyrophosphate imaging in the coronary 
care unit: Although there is undoubtedly still much to 
be learned from infarct-avid imaging, technetium-99m 
pyrophosphate imaging with standard imaging tech- 
niques will not find wide application within the coronary 
care unit. By the time the optimal sensitivity is obtained 
at 48 to 72 hours, the information concerning the pres- 
ence of infarction and its location and extent is to a large 
degree superfluous. To be of clinical value, this infor- 
mation is necessary on admission to the coronary care 
unit. In those patients in whom the question of infarc- 
tion is still unanswered at 48 to 72 hours and in those 
whose onset of symptoms is uncertain, pyrophosphate 
imaging may prove to be of value, but the relatively low 
sensitivity of detecting nontransmural infarction re- 
ported from several centers and the high but still im- 
perfect specificity of the technique raises doubt as to its 
clinical utility even in these circumstances. 
Does infarct-avid imaging with pyrophosphate have 
any role in the evaluation of patients with acute 
myocardial infarction? Pyrophosphate imaging may be 
useful in the detection of peri- and postoperative 
myocardial infarction.41 If the early data of Olson et al.35 
can be confirmed in other centers, pyrophosphate 
imaging would also appear to have a most important 
role, not in the coronary care unit, but in the evaluation 
of patients seen during the early follow-up period after 
hospital discharge after an episode of acute infarction. 
The finding of a persistently positive pyrophosphate 
image suggests a poor prognosis and the need for ther- 
apeutic intervention, whereas the finding of a negative 
image appears to indicate a low risk subset of patients 
in whom high risk interventions should be applied 
cautiously, if at all. Similarly, the patient with unstable 
angina pectoris and a positive pyrophosphate image 
appears to have a different prognosis and to require 
more aggressive therapy than the patient with a nega- 
tive image and an excellent prognosis.36 
Future directions: As we enter the coming decade, 
thallium-201, technetium-99m pyrophosphate and 
blood pool imaging techniques will undoubtedly play 
an increasingly important role in detecting patients with 
ischemic heart disease, selecting high risk subsets for 
therapeutic interventions and evaluating the effects of 
therapeutic interventions, as well as providing further 
insight into the natural history of disease processes. New 
imaging techniques and improvements and develop- 
ments of new radiopharmaceuticals will undoubtedly 
open new areas for clinical investigation. However, the 
challenge of the next several years is to apply more ef- 
ficiently currently available techniques. We must de- 
termine where and when they are cost-effective and an 
aid in clinical decision-making as well as where and 
when they are superfluous, adding only to the cost of 
care without affecting clinical outcome. Although it is 
the role of the clinical investigator to provide this in- 
formation, it is the role of the individual clinician to be 
satisfied that this information is available and reliable 
before he applies these techniques clinically. It is not 
enough that a new technique such as pyrophosphate 
myocardial imaging diagnoses the presence of myo- 
cardial infarction or estimates the size of myocardial 
infarction. To be clinically applicable and to justify the 
expense of the technique, the technique must provide 
information not obtained by less costly techniques and 
must result in clinical decisions affecting patient out- 
come that are otherwise not possible. If these conditions 
can be met, as we believe they will be, and if the tech- 
niques are intelligently applied, we can look forward to 
improved diagnosis and evaluation of patients with 
acute myocardial infarction. 
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